Condition
Premature Ventricular Beats
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Recruiting1
Not Yet Recruiting1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07445334Not ApplicableNot Yet Recruiting
Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes
NCT06949748RecruitingPrimary
Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy
NCT01996618Phase 4UnknownPrimary
Study to Reduce Symptoms of Premature Beats With Ranolazine
Showing all 3 trials